---
layout: page
title: Publications
permalink: /Publications/
---


Rapaport F, Neelamraju Y, Baslan T, Hassane D, Gruszczynska A, Robert de Massy M, et al. Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia. Leukemia. 2021. [Read it here!](https://pubmed.ncbi.nlm.nih.gov/33580203/)

Olson TL, Cheon H, Xing JC, Olson KC, Paila U, Hamele CE, et al. Frequent somatic TET2 mutations in chronic NK-LGL leukemia with distinct patterns of cytopenias. Blood. 2021;138(8):662-73.[Read it here!](https://pubmed.ncbi.nlm.nih.gov/33786584/)

Abshiru NA, Sikora JW, Camarillo JM, Morris JA, Compton PD, Lee T, et al. Targeted detection and quantitation of histone modifications from 1,000 cells. PLoS One. 2020;15(10):e0240829.[Read it here!](https://pubmed.ncbi.nlm.nih.gov/33104722/)

Gokmen-Polar Y, Neelamraju Y, Goswami CP, Gu Y, Gu X, Nallamothu G, et al. Splicing factor ESRP1 controls ER-positive breast cancer by altering metabolic pathways. EMBO Rep. 2019;20(2). [Read it here!](https://pubmed.ncbi.nlm.nih.gov/30665944/)

Neelamraju Y, Gonzalez-Perez A, Bhat-Nakshatri P, Nakshatri H, Janga SC. Mutational landscape of RNA-binding proteins in human cancers. RNA Biol. 2018;15(1):115-29.
[Read it here!](https://pubmed.ncbi.nlm.nih.gov/29023197/) 

Nishtala S, Neelamraju Y, Janga SC. Dissecting the expression relationships between RNA-binding proteins and their cognate targets in eukaryotic post-transcriptional regulatory networks. Sci Rep. 2016; 6:25711. [Read it here!](https://pubmed.ncbi.nlm.nih.gov/27161996/) 

Neelamraju Y, Hashemikhabir S, Janga SC. The human RBPome: from genes and proteins to human disease. J Proteomics. 2015;127(Pt A):61-70. [Read it here!](https://www.sciencedirect.com/science/article/abs/pii/S1874391915002304) 

Hashemikhabir S, Neelamraju Y, Janga SC. Database of RNA binding protein expression and disease dynamics (READ DB). Database (Oxford). 2015;2015: bav072.
[Read it here!](https://academic.oup.com/database/article/doi/10.1093/database/bav072/2433205)

Gokmen-Polar Y, Vladislav IT, Neelamraju Y, Janga SC, Badve S. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers. Sci Rep. 2015; 5:8765. [Read it here!](https://pubmed.ncbi.nlm.nih.gov/25739705/) 

Gokmen-Polar Y, Neelamraju Y, Goswami CP, Gu X, Nallamothu G, Janga SC, et al. Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer. Mod Pathol. 2015;28(5):677-85. [Read it here!](https://pubmed.ncbi.nlm.nih.gov/25431237/)

Chaturvedi P, Neelamraju Y, Arif W, Kalsotra A, Janga SC. Uncovering RNA binding proteins associated with age and gender during liver maturation. Sci Rep. 2015; 5:9512. [Read it here!](https://pubmed.ncbi.nlm.nih.gov/25824884/)


